• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Whose bright idea was it to have managers in the field so much?

DMs have become messengers for marketing and the RDs. They do the grunt work at meetings because as incompetent as they are their boss is even more incompetent. So they put on the work shops and work their asses off for a few days and then go back into semi retirement until the next round of meetings. If you can follow a script and speak to a small group of people without wetting your pants, then you qualify. Years ago they had some independence to design and conduct their own District meetings. Those days are long gone as today it is all top down.

How is that performance measuring up to expectation USLT? What says you Ruud? What excuses will you be making to Frenchy this time around? Investors have had it Frenchy!